Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie L Yang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genes & Development|October 23, 2013
Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expressionSteve Lianoglou, Vidur Garg, Julie L Yang, et al.
BMC Bioinformatics|September 30, 2023
Predicting tumour content of liquid biopsies from cell-free DNAMathias Cardner, Francesco Marass, Erika Gedvilaite, et al.
Nature Biotechnology|November 17, 2015
Affinity regression predicts the recognition code of nucleic acid-binding proteinsRaphael Pelossof, Irtisha Singh, Julie L Yang, et al.
Developmental Cell|December 6, 2023
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreasDavid J Falvo, Adrien Grimont, Paul Zumbo, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is TargetableTamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Blood|February 17, 2023
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosisAndrew J Dunbar, Dongjoo Kim, Min Lu, et al.
Genome Medicine|June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Cancer Discovery|January 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative NeoplasmsAndrew J Dunbar, Robert L Bowman, Young C Park, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genes & Development|October 23, 2013
Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expressionSteve Lianoglou, Vidur Garg, Julie L Yang, et al.
BMC Bioinformatics|September 30, 2023
Predicting tumour content of liquid biopsies from cell-free DNAMathias Cardner, Francesco Marass, Erika Gedvilaite, et al.
Nature Biotechnology|November 17, 2015
Affinity regression predicts the recognition code of nucleic acid-binding proteinsRaphael Pelossof, Irtisha Singh, Julie L Yang, et al.
Developmental Cell|December 6, 2023
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreasDavid J Falvo, Adrien Grimont, Paul Zumbo, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is TargetableTamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Blood|February 17, 2023
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosisAndrew J Dunbar, Dongjoo Kim, Min Lu, et al.
Genome Medicine|June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Cancer Discovery|January 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative NeoplasmsAndrew J Dunbar, Robert L Bowman, Young C Park, et al.
Pageof 2